BioCorRx Inc.

BICX | $1.47 201.91% 200

(0.0% 1d) (65.2% 1m) (-25.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1228.0% volume)
Earnings Calendar:
Market Cap: $ 13,051,469
https://www.biocorrx.com/
Sec Filling | Patents | 3 employees

(United States) a company that changes lives biocorrx® is a leading edge healthcare solutions company focused on improving the lives of those struggling with alcohol and opioid addiction. designed to treat alcoholism and certain opioid addictions, the biocorrx® recovery program is used by a network of independently owned and operated treatment centers located throughout the united states. the program consists of a proprietary long-lasting implant of the fda approved medication, naltrexone, which is proven to substantially reduce cravings for drugs and alcohol. it's a high-quality, comprehensive and cost- effective recovery program built on a strong foundation of experience and practice, allowing for an improved quality of life for recovering addicts.

education

add to watch list Paper trade email alert is off